About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact Report
How connected support across providers, hub services, biopharma and specialty pharmacy helps create a clearer, more coordinated treatment journey for patients.
Read Time
3 minutes
Key Points
Rare disease care is rarely straightforward. For patients and caregivers, the journey to understanding unexplained symptoms is filled with questions, challenges and moments of vulnerability. The path can be complex and emotionally exhausting, and for many, a diagnosis does not come with a clear treatment option. Even when therapies are available, navigating specialist and insurance requirements can make the care experience feel overwhelming.
But out of complexity emerges the power of connection. When care is coordinated across providers, hub services, biopharma and specialty pharmacy, patients and providers can experience a transformation: confusion gives way to clarity, isolation becomes support and uncertainty is met with coordinated care across the treatment journey.
At Biologics by º¬Ð߲ݴ«Ã½, we work with patients and providers to weave together the threads of care to create a powerful, connected network.
“When treatment becomes possible, it can introduce a new kind of stress — one patients and caregivers should feel supported in managing,” said Stephanie Patten, vice president of Rare Disease and Advanced Therapies, Biologics by º¬Ð߲ݴ«Ã½. “Patients and caregivers need a care experience that feels connected, clear and supported. Collaboration across the care team can transform what often feels fragmented into coordinated rare disease care – the kind of experience families deserve.”
According to the National Institutes of Health, a rare disease is defined in the U.S. as a condition that affects fewer than 200,000 people. Collectively, however, an estimated 25-30 million Americans are affected by rare diseases, living with one of the approximately 7,000 identified conditions with a known underlying biological cause.
We remain committed to building the collaborative relationships that make rare disease care possible.
For many, the challenge begins long before treatment. It can take five or more years on average to receive a diagnosis, and patients may move between specialists while also managing travel demands, insurance questions and financial stress. Additionally, rare diseases are usually serious, progressive or life-limiting with only 5% having an FDA-approved treatment.
Rare diseases appear across many specialties, including pediatrics, neurology, nephrology, pulmonology and gastroenterology. Because many clinicians may see only a small number of patients with a specific rare condition in their careers, the administrative steps tied to treatment such as prior authorizations, documentation, benefit verification and hub enrollment may be unfamiliar or time-consuming.
That is why often benefit from partners who can help clarify what is needed, when it is needed and how to keep patients moving forward without unnecessary delays. Specialty pharmacy can help in that role by translating complex therapy requirements into more manageable next steps for both the practice and the patient.
As part of the rare disease provider team, specialty pharmacy plays a key role by acting as an extension of the practice and helping manage the steps involved in starting and maintaining therapy. This support includes:
For , connected support can make a difficult process feel more manageable. Patients deserve a care experience that feels clear, coordinated and supported, especially when they are already navigating uncertainty, evolving medical information and the emotional strain of a rare diagnosis.
That is why collaboration matters in rare disease care. When providers, hub services, biopharma and specialty pharmacy work together, patients are better supported as they move from diagnosis to treatment and beyond.
“At Biologics by º¬Ð߲ݴ«Ã½, we’re honored to stand alongside patients, caregivers and the providers who support them,” Patten says. “And we remain committed to building the collaborative relationships that make rare disease care possible.”
References:
How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.
º¬Ð߲ݴ«Ã½ assists Alchemy to support safety-net clinics in under-resourced communities, an initiative backed by public health advocates focused on improving care for patients living with HIV.
º¬Ð߲ݴ«Ã½ Clinical Research Services (CRS) provides integrated logistics and operational support designed to meet the complexities of clinical trials.
Discover how InspiroGene by º¬Ð߲ݴ«Ã½ is collaborating with Biologics by º¬Ð߲ݴ«Ã½ to streamline cell and gene therapy delivery and accelerate patient access to treatments.
Expanding cancer clinical trials into community oncology settings improves access, accelerates innovation, and enables patient-centered research closer to home.
Pharmacist and Altev Community Pharmacy owner Dr. Emmanuel Ayanjoke shares how Project Oasis helped him turn purpose into impact.
The efforts and innovations enabling local cancer care practices to provide advanced, personalized therapies close to patients’ homes
º¬Ð߲ݴ«Ã½ Amplify enters its second year providing dedicated funding to state pharmacy associations to strengthen independent pharmacies and advance advocacy.
Learn how we help accelerate innovative therapy launches so providers can access them when and where patients need them most.